Which of the following best describes the safety profile of nortriptyline in terms of drug interactions?

• A. Anticholinergic type interactions are common
• B. Strong ventricular arrhythmia risk is the primary concern
• C. Renal failure is a common risk
• D. Ototoxicity is expected

Answer: (A)

Nortriptyline’s safety profile in drug interactions is dominated by its anticholinergic properties. It blocks muscarinic receptors, so when it’s taken with other anticholinergic medications (such as certain antihistamines, antipsychotics, some antidepressants, antispasmodics, or other drugs with anticholinergic effects), these effects add up. The result is an increased risk of anticholinergic side effects like dry mouth, constipation, urinary retention, blurred vision, confusion, and delirium, especially in older adults. This is why anticholinergic type interactions are the most relevant and common concern with nortriptyline. Other issues, like strong ventricular arrhythmia risk, relate to the drug’s direct cardiac effects rather than interactions with other drugs; renal failure is not a typical interaction pattern, and ototoxicity is not a feature of this medication’s interaction profile.